Day: October 8, 2021

Parsec Capital Acquisition Corp. Announces Closing of $86.3 Million Initial Public Offering, Including Full Exercise of Underwriters’ Over-Allotment Option

Parsec Capital Acquisition Corp. Announces Closing of $86.3 Million Initial Public Offering, Including Full Exercise of Underwriters’ Over-Allotment Option

Lewisville, TX, Oct. 08, 2021 (GLOBE NEWSWIRE) — Parsec Capital Acquisition Corp. (NASDAQ: PCXCU) (the “Company”) announced today that it closed its initial public offering of 8,625,000 units at an offering price of $10.00 per unit. This includes the exercise in full by the underwriters of their over-allotment option to purchase up to an additional 1,125,000 units. Each unit consists of one of the Company’s shares of Class A common stock and one redeemable warrant entitling the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable. The units are listed on The NASDAQ Global Market (“NASDAQ”) and began trading under the ticker symbol “PCXCU” on October 6, 2021. Once the securities comprising the units begin separate trading, the shares of Class A common stock...

Continue reading

SHL Holdings Ltd. Addresses Recent Stock Trading and Price Activity

SHL Holdings Ltd. Addresses Recent Stock Trading and Price Activity

HAMILTON, Bermuda, Oct. 08, 2021 (GLOBE NEWSWIRE) — SHL Holdings Ltd. (“SHL” or the “Company”) today addressed recent inquiries from shareholders regarding its stock price movement and trading activity. On September 28, 2021, an amendment to Rule 15c2-11 under the Securities Exchange Act of 1934, as amended, became effective. The amendment requires companies listed on the OTC Pink Market to provide current public financial information, which includes certain financial statements, in order to be quoted. As part of SHL’s approved Plan of Liquidation, the Company prepares a Statement of Net Assets and Changes in Net Assets on a liquidation basis, in accordance with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”). These liquidation basis financial statements do not meet the requirements of the amended Rule 15c2-11 and OTC...

Continue reading

Black Diamond Group Limited Announces Third Quarter 2021 Results Conference Call

Black Diamond Group Limited Announces Third Quarter 2021 Results Conference Call

CALGARY, Alberta, Oct. 08, 2021 (GLOBE NEWSWIRE) — Black Diamond Group Limited (“Black Diamond” or the “Company”) (TSX: BDI), a leading provider of space rental and workforce accommodation, today announced the timing of its 2021 third quarter earnings release and conference call/webcast. Black Diamond intends to release its 2021 third quarter results after markets close on Tuesday, November 2, 2021, and hold a conference call and webcast at 9:00 a.m. MT (11:00 a.m. ET) on Wednesday, November 3, 2021. Chairman and CEO Trevor Haynes and Executive Vice President and CFO Toby LaBrie will discuss Black Diamond’s financial results for the quarter and then take questions from investors and analysts. To access the conference call by telephone dial toll free 1-800-319-4610. International callers should use 1-604-638-5340. Please connect...

Continue reading

- Explanatory Note - Colorado District Court’s Ruling in the Case of GCC vs. Compañía de Inversiones Mercantiles (CIMSA)

– Explanatory Note – Colorado District Court’s Ruling in the Case of GCC vs. Compañía de Inversiones Mercantiles (CIMSA)

CHIHUAHUA, Mexico, Oct. 08, 2021 (GLOBE NEWSWIRE) — GCC, S.A.B. de C.V. (BMV: GCC* or “the Company”), a leading producer of cement and concrete in the United States and Mexico, clarifies that the decision against GCC by the Colorado District Court, which has been circulating in the media, is an ongoing proceeding – not a final ruling. The decision orders GCC to submit assets located in Mexico to the Colorado District Court to guarantee CIMSA the equivalent of $36.1 million dollars plus costs and interest. As previously informed, the highest constitutional court in Bolivia, the country with jurisdiction of origin of the dispute, ruled in favor of GCC in this matter. The company is seeking recognition of the Bolivian proceedings before the Colorado District Court, which would imply dismissing the Colorado District Judge’s...

Continue reading

Three Valley Copper Announces Grant of Deferred Share Units and Restricted Share Units

Three Valley Copper Announces Grant of Deferred Share Units and Restricted Share Units

TORONTO, Oct. 08, 2021 (GLOBE NEWSWIRE) — (TSXV: TVC) Three Valley Copper Corp. (“Three Valley Copper” or the “Company”) announces that it has granted 234,075 Deferred Share Units (DSUs) to directors and 49,938 Restricted Share Units (RSUs) to the CEO pursuant to its long-term incentive plan. The Company intends to grant DSUs quarterly to its directors, with each grant representing one-half of each director’s board retainer, payable in cash or common shares of the Company, upon the holder ceasing to be a director of the Company. The 234,075 DSUs granted reflect the total of owed to directors for the quarters ending March 31, 2021, June 30, 2021 and September 30, 2021. The RSUs granted to the CEO represent 20% of the base compensation of the CEO and are payable in common shares of the Company on exercise, and vest on January 1 of...

Continue reading

Elcora Closes Second and Final Tranche of Private Placement

Elcora Closes Second and Final Tranche of Private Placement

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. HALIFAX, Nova Scotia, Oct. 08, 2021 (GLOBE NEWSWIRE) — ELCORA ADVANCED MATERIALS CORP. (TSX.V:ERA | Frankfurt:ELM | OTC – ECORF), (the “Company” or “Elcora”), is pleased to announce that it has closed a second and final tranche of its previously announced (see news release dated September 23, 2021) non-brokered private placement (the “Offering”). The Company issued 33,983,700 units at a price of $0.05 per Unit for gross proceeds of $1,699,185.00 for the second and final tranche. In total, the Company issued 56,393,700 Units at $0.05 for aggregate gross proceeds of $2,819,685.00. Each Unit will consist of one (1) common share and one (1)...

Continue reading

Horizon Acquisition Corp. Announces Delisting of its Securities Effective and Conditional Upon Consummation of its Pending Business Combination with Vivid Seats Inc.

Horizon Acquisition Corp. Announces Delisting of its Securities Effective and Conditional Upon Consummation of its Pending Business Combination with Vivid Seats Inc.

Business Combination remains subject to satisfaction of customary closing conditions, including approval of Horizon shareholders NEW YORK, Oct. 08, 2021 (GLOBE NEWSWIRE) — Horizon Acquisition Corp. (NYSE: HZAC) (“Horizon” or the “Company”) announced today that, assuming satisfaction of the conditions to the closing of its pending business combination with Vivid Seats Inc. (“Vivid Seats”) (the “Business Combination”), including approval of the Business Combination by the Company’s shareholders, Vivid Seats, as the surviving entity, intends to list its common shares and warrants on The Nasdaq Capital Market (the “Nasdaq”) under the ticker symbols “SEAT” and “SEAT WS,” respectively and that Horizon intends to voluntarily delist all of its securities from The New York Stock Exchange (“NYSE”), including each of Horizon’s units, public...

Continue reading

Scopus BioPharma Announces Adjournment of Annual Meeting of Stockholders

Scopus BioPharma Announces Adjournment of Annual Meeting of Stockholders

NEW YORK, Oct. 08, 2021 (GLOBE NEWSWIRE) — Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need, today announced that, on October 8, 2021, its 2021 Annual Meeting of Stockholders (the “Annual Meeting”) was adjourned to 1:00 p.m., Eastern time, on Friday, November 5, 2021, without any business being conducted, pursuant to a Stipulation and Court Order approved by the Delaware Court of Chancery between Scopus and Morris C. Laster, M.D. in connection with Dr. Laster’s pending claims against Scopus in the Delaware Court of Chancery. Notwithstanding the Stipulation and Court Order requiring Dr. Laster to cause all shares of Scopus common stock held by him to be present in person or by proxy at the Annual Meeting...

Continue reading

Pilgrim’s Pride to Release Third Quarter 2021 Financial Results October 27

Pilgrim’s Pride to Release Third Quarter 2021 Financial Results October 27

GREELEY, Colo., Oct. 08, 2021 (GLOBE NEWSWIRE) — Pilgrim’s Pride Corporation (NASDAQ: PPC) announced today that it will release its third quarter 2021 financial results after the U.S. market closes on October 27, 2021. The Company’s executives will review the results on a conference call and webcast Thursday, October 28, 2021, at 7:00 a.m. MT (9:00 a.m. ET). Investors and analysts may pre-register for the webcast to receive a unique PIN to gain immediate access to the call and bypass the live operator. Pre-registration may be completed at any time, including up to and after the call has begun, by accessing the company’s investor website at https://ir.pilgrims.com in the “Events & Presentations” section. Participants also can register for the conference call and webcast at https://services.choruscall.com/links/ppc211028.html....

Continue reading

Liquidia Receives Favorable Ruling in Inter Partes Review against United Therapeutics Patent

Liquidia Receives Favorable Ruling in Inter Partes Review against United Therapeutics Patent

MORRISVILLE, N.C., Oct. 08, 2021 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) announced today that the U.S. Patent Trial and Appeal Board (PTAB) ruled in its favor in the Inter Partes Review (IPR) proceeding against U.S. Patent No. 9,604,901 (‘901 patent) owned by United Therapeutics Corporation (UTC) and listed in the Orange Book for Tyvaso® (treprostinil inhalation solution). In its ruling, the PTAB found that seven of the nine claims were unpatentable. Only the narrower dependent claims 6 and 7 remain, both of which require actual storage at ambient temperature of treprostinil sodium. The PTAB’s decision primarily relates to the issue of patentability based on a review of prior art. This decision does not preclude the invalidation of the remaining claims on other grounds as part of the ongoing Hatch Waxman litigation,...

Continue reading